• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Epidemiol Infect . Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural c

tetano

Editor, Senior Moderator
Epidemiol Infect


. 2022 Mar 3;150:e58.
doi: 10.1017/S0950268822000346.
Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural cohort of eastern India


Pujarini Dash[SUP] 1 [/SUP], Asit Mansingh[SUP] 1 [/SUP], Soumya Ranjan Nayak[SUP] 1 [/SUP], Debadutta Sahoo[SUP] 1 [/SUP], Debdutta Bhattacharya[SUP] 1 [/SUP], Srikanta Kanungo[SUP] 1 [/SUP], Jaya Singh Kshatri[SUP] 1 [/SUP], Bijaya Kumar Mishra[SUP] 1 [/SUP], Matrujyoti Pattnaik[SUP] 1 [/SUP], Debaprasad Parai[SUP] 1 [/SUP], Hari Ram Choudhary[SUP] 1 [/SUP], Swetalina Nayak[SUP] 1 [/SUP], Khokan Rana[SUP] 1 [/SUP], Alice Alice[SUP] 1 [/SUP], Ajay Kumar Sahoo[SUP] 1 [/SUP], Kanhu Charan Mohanty[SUP] 1 [/SUP], Prasantajyoti Mohanty[SUP] 1 [/SUP], Chinki Doley[SUP] 1 [/SUP], Hitesh Jain[SUP] 1 [/SUP], Dasharatha Majhi[SUP] 1 [/SUP], Pooja Pattanayak[SUP] 1 [/SUP], Santosh Behuria[SUP] 1 [/SUP], Soumya Panda[SUP] 1 [/SUP], Somnath Bhoi[SUP] 1 [/SUP], Sanghamitra Pati[SUP] 1 [/SUP], Subrata Kumar Palo[SUP] 1 [/SUP]



Affiliations

Abstract

COVID-19 serosurvey provides a better estimation of people who have developed antibody against the infection. But limited information on such serosurveys in rural areas poses many hurdles to understand the epidemiology of the virus and to implement proper control strategies. This study was carried out in the rural catchment area of Model Rural Health Research Unit in Odisha, India during March-April 2021, the initial phase of COVID vaccination. A total of 60 village clusters from four study blocks were identified using probability proportionate to size sampling. From each cluster, 60 households and one eligible participant from each household (60 per cluster) were selected for the collection of blood sample and socio-demographic data. The presence of SARS-CoV-2 antibody was tested using the Elecsys Anti-SARS-CoV-2 immunoassay. The overall seroprevalence after adjusting for test performance was 54.21% with an infection to case ratio of 96.89 along with 4.25% partial and 6.79% full immunisation coverage. Highest seroprevalence was observed in the age group of 19-44 years and females had both higher seroprevalence as well as vaccine coverage. People of other backward caste also had higher seropositivity than other caste categories. The study emphasises on continuing surveillance for COVID-19 cases and prioritizing COVID-19 vaccination for susceptible groups for better disease management.

Keywords: Coronavirus; epidemiology; rural area; sero-survey.
 
Back
Top Bottom